Clik here to view.
Boston Scientific launches Dakota nitinol kidney stone retrieval device
Boston Scientific (NYSE:BSX) said today it launched its Dakota nitinol retrieval device designed for kidney stone retrieval in the U.S. and Europe. The Dakota stone retrieval device is designed to work...
View ArticleClik here to view.
ECRI lists the top 10 medical device hazards
The ECRI Institute this month released its top 10 health technology hazards for the next year, with Infusion errors and inadequate cleaning of reusable instruments topping the list. The ECRI institute...
View ArticleClik here to view.
Baxter adds $1.5B to share buyback plan
Baxter (NYSE:BAX) said today its board of directors approved a $1.5 billion increase in its share repurchase plan as it announced its quarterly cash dividend of 13¢. The share repurchase plan, which...
View ArticleClik here to view.
DJO Global pares losses down over 80% in Q3 earnings
DJO Global today released its 3rd quarter earnings, seeing losses pared down 87% while sales grew just over 3%. The San Diego, Calif.-based company posted losses of $22.5 million on sales of $287...
View ArticleClik here to view.
Appeals court reverses AngioScore win over TriReme
The U.S. Court of Appeals for the Federal Circuit overturned a ruling in favor of AngioScore in a patent infringement case between it and TriReme Medical and a pair of related companies. The court...
View ArticleClik here to view.
New FDA/EMA rare diseases and patient engagement clusters underway
By: Jonathan Goldsmith, M.D., FACP, and Sandy Kweder, M.D., RADM (Ret.) US Public Health Service Drug development and approval happens across the globe and we at FDA strive to collaborate with other...
View ArticleClik here to view.
Gold nanoparticles target chromosomes in cancer cells
Researchers tagged gold nanoparticles with a small dose of radiation to trace the particles as they deliver a drug into the heart of a cancer cell, according to work presented at the 2016 National...
View ArticleClik here to view.
Trump win boosts drug stocks
Pharmaceutical stocks surged today after Donald Trump won the U.S. presidential election, as investors concluded the threat of action on drug pricing had lessened. California’s Proposition 61, which...
View ArticleClik here to view.
Court quashes American Medical Systems subpoenas in pelvic mesh case, to mull...
The federal court overseeing the multidistrict litigation over pelvic mesh products made by American Medical Systems, the erstwhile women’s health business once owned by Endo International (NSDQ:ENDP),...
View ArticleClik here to view.
Aum Cardiovascular releases preliminary data from Turbulence study
Aum Cardiovascular today released preliminary results from the pivotal clinical trial of its Cadence heart disease diagnostics device, touting the device’s efficacy at detecting significant obstructive...
View ArticleClik here to view.
FDA warns Valeant on SPAG-2 nebulizer, OraPharma OnSet mixing pen
The FDA this month warned Valeant Pharmaceuticals (NYSE:VRX) on violations found during inspections of its Rochester, N.Y., plant last summer. The federal safety watchdog, in a Nov. 3 warning letter...
View ArticleClik here to view.
Ex-Cyberonics rep asks appeals court to reinstate whistleblower suit
A former Cyberonics (NSDQ:CYBX) sales rep this week asked the 1st Circuit Court of Appeals to reinstate a File Claims Act suit, claiming his allegations were sufficient to show that the company pressed...
View ArticleClik here to view.
Ocular Therapeutix plans FDA re-submission for Dextenza by end of year, earnings
Shares in Ocular Therapeutix (NSDQ:OCUL) surged this morning after the biopharmaceutical company met expectations on Wall Street with its 3rd-quarter results and announced it will re-submit its new...
View ArticleClik here to view.
Trump win augurs well for healthcare stocks
Donald Trump’s shocking upset in the U.S. presidential race augurs well for healthcare stocks, as industry can expect lower taxes, and deregulation and the dismantling of Obamacare – including the...
View ArticleClik here to view.
TransEnterix inks distribution deal Down Under for Senhance surgical robot
TransEnterix (NYSE:TRXC) said today it signed an distribution deal with Getz Healthcare for its Senhance surgical robotics system. The deal will position Getz Healthcare as the exclusive distributor of...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 9, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
GI Dynamics touts real-world EndoBarrier data
GI Dynamics (ASX:GID) today released German registry data on its EndoBarrier device, touting lowered insulin usage and significant weight loss. Data, which came from 234 patients enrolled in the...
View ArticleClik here to view.
Clearside tops Q3 estimates, posts license revenue
Shares in Clearside Biomedical (NSDQ:CLSD) rose today after the biopharmaceutical company met expectations on Wall Street with its 3rd quarter results. The Alpharetta, Ga.-based company posted losses...
View ArticleClik here to view.
Paralyzed monkeys walk again with wireless ‘brain-spine interface’
Swiss scientists from the Swiss Federal Institute of Technology helped paralyzed monkeys walk again with a neuroprosthetic interface that acts as a wireless bridge between the brain and the spine,...
View ArticleClik here to view.
Researchers develop artificial cells as drug delivery vehicles
Researchers from the Eindhoven University of Technology in Netherlands have developed artificial cells that use enzymes to move like real cells and navigate complex environments, according to a study...
View Article